TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Egetis Therapeutics AB (publ)
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 22,600 | 38,243 | 40,662 |
Financial expenses | 700 | 188 | 889 |
Earnings before taxes | -193,800 | -104,542 | -179,120 |
EBITDA | -195,400 | -103,226 | -178,000 |
Total assets | 561,100 | 569,269 | 893,967 |
Current assets | 147,400 | 152,902 | 299,871 |
Current liabilities | 49,400 | 39,170 | 70,142 |
Equity capital | 506,200 | 527,039 | 629,627 |
- share capital | 11,300 | 8,688 | 8,688 |
Employees (average) | 15 | 11 | 9 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 90.2% | 92.6% | 70.4% |
Turnover per employee | 1,507 | 3,477 | 4,518 |
Profit as a percentage of turnover | -857.5% | -273.4% | -440.5% |
Return on assets (ROA) | -34.4% | -18.3% | -19.9% |
Current ratio | 298.4% | 390.4% | 427.5% |
Return on equity (ROE) | -38.3% | -19.8% | -28.4% |
Change turnover | -15,643 | -2,419 | -41,900 |
Change turnover % | -41% | -6% | -51% |
Chg. No. of employees | 4 | 2 | 0 |
Chg. No. of employees % | 36% | 22% | 0% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.